NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
08/11/2026
Back to search
Official data from USPTO
S-CELTENSIFY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/11/2026
Trademark type
Combined
Nice classes
40, 42
Filing date
10/16/2024
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
08/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
CROSS, TRACY L
Current location
Historical data usage
Mark description
The mark consists of the stylized wording "S-Celtensify".
Holders and representatives
Holders
Samsung Biologics Co., Ltd.
Representatives
Brian P. Gregg McNees Wallace & Nurick
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylated drugs; processing of chemicals.
Class 42
Scientific laboratory services for high-efficiency glycan analysis; culturing of cells for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid analysis; protein analysis; toxicity analysis; scientific research in the field of molecular analysis; development of biotechnology; biotechnological research; scientific research in the field of biological analysis; biological research; scientific research in the field of biologics; scientific research in the field of biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; testing services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetics; computer programming in the medical field; medical research laboratories; * technical support for * computer * software in the field of * project management * of * services relating to imaging medical * imaging * data; medicine research; analysis and evaluation of medical product development; providing information on the testinginspection and research of medical products; providing medical and scientific research information in the field of clinical trial progress; scientific research in the nature of conducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/22/2026
FIMP
FINAL DISPOSITION PROCESSED
07/22/2026
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
07/22/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/21/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/21/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/28/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/11/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/11/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/11/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/31/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/23/2025
PUBO
PUBLISHED FOR OPPOSITION
09/23/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/17/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/23/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/18/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2025
RFNT
REFUSAL PROCESSED BY IB
05/09/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/18/2025
RFRR
REFUSAL PROCESSED BY MPU
04/18/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2025
CNRT
NON-FINAL ACTION WRITTEN
03/11/2025
DOCK
ASSIGNED TO EXAMINER
03/07/2025
MAFR
APPLICATION FILING RECEIPT MAILED
12/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2024
Continuous trademark protection
Get notified about every new filing that threatens S-CELTENSIFY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.